Data from a longitudinal study with >38,000 individuals found that APOE-ε4 carriers and females with higher CSF TNF-α, IL-9, and IL-12p40 levels were at the highest risk of progression to MCI/AD (Contreras et al., 2022). This evidence concerns the gene IL9 and Alzheimer disease.